Analysis of tumor-derived DNA in plasma and bone marrow fluid in lung cancer patients Taichiro GotoYosuke HirotsuMasao Omata Short Communication 20 February 2016 Article: 29
Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials Francesco A. D’AngeloLaura AntolinoGiovanni Ramacciato Review Paper 17 February 2016 Article: 28
Comparison of toxicity profile and tolerability between two standard of care paclitaxel-based adjuvant chemotherapy regimens in breast cancer Mohamed AlsharediTodd GressMaria Tria Tirona Original Paper 16 February 2016 Article: 27
APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma Keisuke KosumiYoshifumi BabaHideo Baba Original Paper 15 February 2016 Article: 26
Is ERAS in laparoscopic surgery for colorectal cancer changing risk factors for delayed recovery? Michał PędziwiatrMagdalena PisarskaOlle Ljungqvist Original Paper Open access 12 February 2016 Article: 25
STAT3 polymorphism rs4796793 may be a predictive factor of tumor response to multiple tyrosine kinase inhibitors in metastatic renal cell carcinoma in Japanese population Kazuhiro YamamotoTakeshi IoroiMidori Hirai Original Paper 30 January 2016 Article: 24
Telomerase activity in breast cancer patients: association with poor prognosis and more aggressive phenotype Ana KulićNatalija Dedić PlavetićMaja Sirotković-Skerlev Original Paper 30 January 2016 Article: 23
The P21-activated kinase expression pattern is different in non-small cell lung cancer and affects lung cancer cell sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors Yang LiuSi WangEn-Hua Wang Original Paper 28 January 2016 Article: 22
Epigenetic regulation of E-cadherin expression by the histone demethylase UTX in colon cancer cells Lin ZhaQiang CaoHang Shi Original Paper 27 January 2016 Article: 21
